Attached files
| file | filename |
|---|---|
| EX-10.2 - EXHIBIT 10.2 - Cantabio Pharmaceuticals Inc. | exhibit_10_2.htm |
| EX-10.11 - EXHIBIT 10.11 - Cantabio Pharmaceuticals Inc. | exhibit_10_11.htm |
| EX-5.1 - EXHIBIT 5.1 - Cantabio Pharmaceuticals Inc. | exhibit_5_1.htm |
| EX-4.1 - EXHIBIT 4.1 - Cantabio Pharmaceuticals Inc. | exhibit_4_1.htm |
| S-1 - REGISTRATION STATEMENT ON FORM S-1 - Cantabio Pharmaceuticals Inc. | cantabio_s1.htm |
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM’S CONSENT
We consent to the inclusion in this Registration Statement of Cantabio Pharmaceuticals Inc. on Form S-1 of our report dated July 14, 2016, which includes an explanatory paragraph as to the Company’s ability to continue as a going concern with respect to our audits of the financial statements of Cantabio Pharmaceuticals Inc. as of March 31, 2016 and 2015 and for the years ended March 31, 2016 and 2015, which report appears in the Prospectus, which is part of this Registration Statement. We also consent to the reference to our Firm under the heading “Experts” in such Prospectus.
/s/ Marcum
Marcum LLP
New York, NY
May 5, 2017